These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25343355)

  • 21. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
    Fast DJ; Vosika GJ
    Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.
    Ke Y; McGraw CL; Hunter RL; Kapp JA
    Cell Immunol; 1997 Mar; 176(2):113-21. PubMed ID: 9073383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant activities of CTAB-modified Polygonatum sibiricum polysaccharide cubosomes on immune responses to ovalbumin in mice.
    Liu Z; Ni H; Yu L; Xu S; Bo R; Qiu T; Gu P; Zhu T; He J; Wusiman A; Zhu S; Liu J; Hu Y; Wang D
    Int J Biol Macromol; 2020 Apr; 148():793-801. PubMed ID: 31972196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens.
    Prajeeth CK; Jirmo AC; Krishnaswamy JK; Ebensen T; Guzman CA; Weiss S; Constabel H; Schmidt RE; Behrens GM
    Eur J Immunol; 2010 May; 40(5):1272-83. PubMed ID: 20213735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
    Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
    ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
    Nalefski EA; Rao A
    J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity.
    Prokopowicz ZM; Arce F; Biedroń R; Chiang CL; Ciszek M; Katz DR; Nowakowska M; Zapotoczny S; Marcinkiewicz J; Chain BM
    J Immunol; 2010 Jan; 184(2):824-35. PubMed ID: 20018624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
    Ke Y; Li Y; Kapp JA
    Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microparticulate β-glucan vaccine conjugates phagocytized by dendritic cells activate both naïve CD4 and CD8 T cells in vitro.
    Berner VK; duPre SA; Redelman D; Hunter KW
    Cell Immunol; 2015; 298(1-2):104-14. PubMed ID: 26549577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
    Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
    Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens.
    Fritz JH; Brunner S; Birnstiel ML; Buschle M; Gabain Av; Mattner F; Zauner W
    Vaccine; 2004 Sep; 22(25-26):3274-84. PubMed ID: 15308350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
    Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
    J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A; Snyder D; Gilboa E
    J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.